Charles P O'Brien. Show Affiliations »
Abstract
Mesh： See more » AcamprosateAlcohol Deterrents/pharmacologyAlcohol Deterrents/therapeutic useAlcohol Drinking/physiopathologyAlcohol Drinking/psychologyAlcoholism/drug therapyAlcoholism/physiopathologyAlcoholism/prevention & controlBehavior, Addictive/drug therapyBehavior, Addictive/physiopathologyBehavior, Addictive/prevention & controlDisease Models, AnimalEndorphins/drug effectsEndorphins/physiologyEthanol/pharmacologyEuphoria/drug effectsHumansNaltrexone/pharmacologyNaltrexone/therapeutic useReceptors, Dopamine D2/drug effectsReceptors, Dopamine D2/geneticsReceptors, Dopamine D2/physiologyReceptors, Opioid/drug effectsReceptors, Opioid/geneticsReceptors, Opioid/physiologySecondary PreventionTaurine/analogs & derivativesTaurine/pharmacologyTaurine/therapeutic use
Substances： See more » Alcohol DeterrentsEndorphinsReceptors, Dopamine D2Receptors, OpioidTaurineEthanolNaltrexoneAcamprosate
Year: 2004 PMID： 15465965 DOI： 10.1176/ajp.161.10.1741
Source DB: PubMed Journal: Am J Psychiatry ISSN： 0002-953X Impact factor: 18.112